Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
301
Nova Eye Medical Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,474.60 | 23.70 | 0.28% |
| CAC 40 | 7,216.83 | 10.15 | -0.14% |
| DAX 40 | 19,003.11 | 30.53 | -0.16% |
| Dow JONES (US) | 43,958.19 | 47.21 | 0.11% |
| FTSE 100 | 8,030.33 | 4.56 | 0.06% |
| HKSE | 19,649.91 | 173.54 | -0.88% |
| NASDAQ | 19,230.72 | 50.68 | -0.26% |
| Nikkei 225 | 38,752.07 | 30.41 | 0.08% |
| NZX 50 Index | 12,692.94 | 18.45 | 0.15% |
| S&P 500 | 5,985.38 | 1.39 | 0.02% |
| S&P/ASX 200 | 8,220.80 | 27.40 | 0.33% |
| SSE Composite Index | 3,428.37 | 10.90 | -0.32% |